BIOMAT Database Logo BIOMAT Database Logo

[Blood serum osteocalcin and beta-crosslaps concentrations in patients after renal transplantation]. 2007

Zbigniew Zbróg, and Małgorzata Tomaszek, and Adam Szuflet, and Teresa Pierzchalska-Mudyna, and Agnieszka Rybińska, and Agnieszka Skrzypek, and Józef Matych
Oddział Nefrologii WSS im. M. Kopernika, Łódź. zbigniewzbrog@interia.pl

In 16 patients (7 males, 9 females), aged 47.2 +/- 15.9 years, blood serum concentrations of osteocalcin, beta-crosslaps, parathormone, calcium, phosphate, creatinine and urea were determined before renal transplantation and 3 and 6 months following the procedure. Three as well as six months following renal transplantation significant decrease in blood serum concentration of osteocalcin and beta-crosslaps are found. A significant positive correlation between osteocalcin and beta-crosslaps concentration was found in each investigated period. Six-months observation revealed only partial correction of bone metabolism following renal transplantation.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010012 Osteogenesis The process of bone formation. Histogenesis of bone including ossification. Bone Formation,Ossification, Physiologic,Endochondral Ossification,Ossification,Ossification, Physiological,Osteoclastogenesis,Physiologic Ossification,Endochondral Ossifications,Ossification, Endochondral,Ossifications,Ossifications, Endochondral,Osteoclastogeneses,Physiological Ossification
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D001862 Bone Resorption Bone loss due to osteoclastic activity. Bone Loss, Osteoclastic,Osteoclastic Bone Loss,Bone Losses, Osteoclastic,Bone Resorptions,Loss, Osteoclastic Bone,Losses, Osteoclastic Bone,Osteoclastic Bone Losses,Resorption, Bone,Resorptions, Bone
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine

Related Publications

Zbigniew Zbróg, and Małgorzata Tomaszek, and Adam Szuflet, and Teresa Pierzchalska-Mudyna, and Agnieszka Rybińska, and Agnieszka Skrzypek, and Józef Matych
Osteocalcin serum levels in patients following renal transplantation.
March 1989, Klinische Wochenschrift,
Zbigniew Zbróg, and Małgorzata Tomaszek, and Adam Szuflet, and Teresa Pierzchalska-Mudyna, and Agnieszka Rybińska, and Agnieszka Skrzypek, and Józef Matych
[Serum beta-CTx(beta-CrossLaps)].
February 2004, Nihon rinsho. Japanese journal of clinical medicine,
Zbigniew Zbróg, and Małgorzata Tomaszek, and Adam Szuflet, and Teresa Pierzchalska-Mudyna, and Agnieszka Rybińska, and Agnieszka Skrzypek, and Józef Matych
Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers.
March 2001, Clinical biochemistry,
Zbigniew Zbróg, and Małgorzata Tomaszek, and Adam Szuflet, and Teresa Pierzchalska-Mudyna, and Agnieszka Rybińska, and Agnieszka Skrzypek, and Józef Matych
Serum osteocalcin levels in patients after kidney transplantation.
May 1990, Clinical nephrology,
Zbigniew Zbróg, and Małgorzata Tomaszek, and Adam Szuflet, and Teresa Pierzchalska-Mudyna, and Agnieszka Rybińska, and Agnieszka Skrzypek, and Józef Matych
Predictive value of osteocalcin and beta-CrossLaps in metastatic breast cancer.
November 2007, Clinical biochemistry,
Zbigniew Zbróg, and Małgorzata Tomaszek, and Adam Szuflet, and Teresa Pierzchalska-Mudyna, and Agnieszka Rybińska, and Agnieszka Skrzypek, and Józef Matych
Serum concentrations of osteocalcin, procollagen type 1 N-terminal propeptide and beta-CrossLaps in obese subjects with varying degrees of glucose tolerance.
August 2011, Clinical endocrinology,
Zbigniew Zbróg, and Małgorzata Tomaszek, and Adam Szuflet, and Teresa Pierzchalska-Mudyna, and Agnieszka Rybińska, and Agnieszka Skrzypek, and Józef Matych
Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation.
June 1985, The Journal of clinical endocrinology and metabolism,
Zbigniew Zbróg, and Małgorzata Tomaszek, and Adam Szuflet, and Teresa Pierzchalska-Mudyna, and Agnieszka Rybińska, and Agnieszka Skrzypek, and Józef Matych
Relationships of cyclosporine concentrations in serum, whole blood, and bile after renal and hepatic transplantation.
October 1986, Clinical chemistry,
Zbigniew Zbróg, and Małgorzata Tomaszek, and Adam Szuflet, and Teresa Pierzchalska-Mudyna, and Agnieszka Rybińska, and Agnieszka Skrzypek, and Józef Matych
Serum osteocalcin concentrations in patients with rheumatoid arthritis.
August 1989, Annals of the rheumatic diseases,
Zbigniew Zbróg, and Małgorzata Tomaszek, and Adam Szuflet, and Teresa Pierzchalska-Mudyna, and Agnieszka Rybińska, and Agnieszka Skrzypek, and Józef Matych
Serum osteocalcin concentrations in patients with rheumatoid arthritis.
April 1990, Annals of the rheumatic diseases,
Copied contents to your clipboard!